Business Description
CareDx Inc
NAICS : 325413
SIC : 8071
ISIN : US14167L1035
Share Class Description:
STU:1K9: Ordinary SharesDescription
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.04 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.97 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | -107.8 | |||||
| 3-Year EPS without NRI Growth Rate | -78.1 | |||||
| 3-Year Book Growth Rate | -3.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.84 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.11 | |||||
| 9-Day RSI | 49.17 | |||||
| 14-Day RSI | 45.76 | |||||
| 6-1 Month Momentum % | 208.63 | |||||
| 12-1 Month Momentum % | 381.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | |||||
| Quick Ratio | 3.87 | |||||
| Cash Ratio | 2.96 | |||||
| Days Inventory | 65.51 | |||||
| Days Sales Outstanding | 69.01 | |||||
| Days Payable | 29.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 2.48 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.77 | |||||
| Operating Margin % | -18.77 | |||||
| Net Margin % | -45.9 | |||||
| FCF Margin % | 0.38 | |||||
| ROE % | -49.52 | |||||
| ROA % | -30.36 | |||||
| ROIC % | -29.91 | |||||
| 3-Year ROIIC % | -184.97 | |||||
| ROC (Joel Greenblatt) % | -74.8 | |||||
| ROCE % | -14.8 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 45.38 | |||||
| PS Ratio | 3.97 | |||||
| PB Ratio | 4.6 | |||||
| Price-to-Tangible-Book | 6.51 | |||||
| Price-to-Free-Cash-Flow | 1075 | |||||
| Price-to-Operating-Cash-Flow | 160.88 | |||||
| EV-to-EBIT | -18.01 | |||||
| EV-to-EBITDA | -27.4 | |||||
| EV-to-Revenue | 3.38 | |||||
| EV-to-Forward-Revenue | 3.03 | |||||
| EV-to-FCF | 865.43 | |||||
| Price-to-Projected-FCF | 73.97 | |||||
| Price-to-Median-PS-Value | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 9.65 | |||||
| Price-to-Net-Cash | 33.62 | |||||
| Earnings Yield (Greenblatt) % | -5.55 | |||||
| FCF Yield % | 0.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CareDx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 286.813 | ||
| EPS (TTM) (€) | -2.465 | ||
| Beta | 3.76 | ||
| Volatility % | 121.9 | ||
| 14-Day RSI | 45.76 | ||
| 14-Day ATR (€) | 1.02209 | ||
| 20-Day SMA (€) | 22.6635 | ||
| 12-1 Month Momentum % | 381.97 | ||
| 52-Week Range (€) | 6.7 - 31.59 | ||
| Shares Outstanding (Mil) | 53.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CareDx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CareDx Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CareDx Inc Frequently Asked Questions
What is CareDx Inc(STU:1K9)'s stock price today?
The current price of STU:1K9 is €22.19. The 52 week high of STU:1K9 is €31.59 and 52 week low is €6.70.
When is next earnings date of CareDx Inc(STU:1K9)?
The next earnings date of CareDx Inc(STU:1K9) is 2025-02-28 Est..
Does CareDx Inc(STU:1K9) pay dividends? If so, how much?
CareDx Inc(STU:1K9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers